sesamin has been researched along with Colorectal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Huang, Y; Jiang, M; Li, J; Li, L; Liu, Z; Tang, Y; Zhou, L | 1 |
| Huang, Y; Qiao, J; Wang, X; Zhao, Y; Zou, C | 1 |
2 other study(ies) available for sesamin and Colorectal Neoplasms
| Article | Year |
|---|---|
Sesamin inhibits hypoxia-stimulated angiogenesis
Topics: Animals; Cell Line, Tumor; Colorectal Neoplasms; Dioxoles; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Lignans; Mice; Mice, Nude; Neovascularization, Pathologic; NF-kappa B; Signal Transduction; Vascular Endothelial Growth Factor A | 2022 |
Sesamin induces cell cycle arrest and apoptosis through p38/C-Jun N-terminal kinase mitogen-activated protein kinase pathways in human colorectal cancer cells.
Topics: Animals; Antioxidants; Apoptosis; Cell Cycle; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Cyclin D1; Dioxoles; Dose-Response Relationship, Drug; Humans; JNK Mitogen-Activated Protein Kinases; Lignans; Mice; Mice, Inbred BALB C; p38 Mitogen-Activated Protein Kinases; Signal Transduction; Time Factors; Up-Regulation | 2021 |